Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Author:

Ajani Jaffer A.1,D’Amico Thomas A.2,Bentrem David J.3,Chao Joseph4,Corvera Carlos5,Das Prajnan1,Denlinger Crystal S.6,Enzinger Peter C.7,Fanta Paul8,Farjah Farhood9,Gerdes Hans10,Gibson Michael11,Glasgow Robert E.12,Hayman James A.13,Hochwald Steven14,Hofstetter Wayne L.1,Ilson David H.10,Jaroszewski Dawn15,Johung Kimberly L.16,Keswani Rajesh N.3,Kleinberg Lawrence R.17,Leong Stephen18,Ly Quan P.19,Matkowskyj Kristina A.20,McNamara Michael21,Mulcahy Mary F.3,Paluri Ravi K.22,Park Haeseong23,Perry Kyle A.24,Pimiento Jose25,Poultsides George A.26,Roses Robert27,Strong Vivian E.10,Wiesner Georgia11,Willett Christopher G.2,Wright Cameron D.28,McMillian Nicole R.29,Pluchino Lenora A.29

Affiliation:

1. 1The University of Texas MD Anderson Cancer Center;

2. 2Duke Cancer Institute;

3. 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

4. 4City of Hope National Medical Center;

5. 5UCSF Helen Diller Family Comprehensive Cancer Center;

6. 6Fox Chase Cancer Center;

7. 7Dana-Farber/Brigham and Women’s Cancer Center;

8. 8UC San Diego Moores Cancer Center;

9. 9Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

10. 10Memorial Sloan Kettering Cancer Center;

11. 11Vanderbilt-Ingram Cancer Center;

12. 12Huntsman Cancer Institute at the University of Utah;

13. 13University of Michigan Rogel Cancer Center;

14. 14Roswell Park Comprehensive Cancer Center;

15. 15Mayo Clinic Cancer Center;

16. 16Yale Cancer Center/Smilow Cancer Hospital;

17. 17The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

18. 18University of Colorado Cancer Center;

19. 19Fred & Pamela Buffett Cancer Center;

20. 20University of Wisconsin Carbone Cancer Center;

21. 21Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

22. 22O'Neal Comprehensive Cancer Center at UAB;

23. 23Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

24. 24The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

25. 25Moffitt Cancer Center;

26. 26Stanford Cancer Institute;

27. 27Abramson Cancer Center at the University of Pennsylvania;

28. 28Massachusetts General Hospital Cancer Center; and

29. 29National Comprehensive Cancer Network

Abstract

AbstractEsophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and adenocarcinoma is most common in North America and Western Europe. Surgery is a major component of treatment of locally advanced resectable esophageal and esophagogastric junction (EGJ) cancer, and randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival. Targeted therapies including trastuzumab, ramucirumab, and pembrolizumab have produced encouraging results in the treatment of patients with advanced or metastatic disease. Multidisciplinary team management is essential for all patients with esophageal and EGJ cancers. This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.

Publisher

Harborside Press, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3